Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heart device offers hope for AFib patients who can't use blood thinners

NCT ID NCT05224375

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 23 times

Summary

This study tested a device called the Laminar Left Atrial Appendage Closure System in 29 adults with atrial fibrillation (an irregular heartbeat) who are at high risk for stroke but cannot take blood thinners. The device is placed to seal off a small pouch in the heart where clots often form. The goal was to see if the device safely closes the pouch and reduces the risk of stroke or major bleeding.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Tbilisi Heart and Vascular Clinic

    Tbilisi, Georgia

Conditions

Explore the condition pages connected to this study.